Every Company Closes $175 Million Series C

<p><strong>SAN FRANCISCO<&sol;strong> &&num;8212&semi; The EVERY Company &lpar;formerly Clara Foods&rpar;&comma; developer of animal-free protein&comma; has closed &dollar;175 million in Series C financing&period; The round was co-led by new investor&comma; McWin&comma; and existing investor&comma; Rage Capital&period; Other new and existing investors joined the round including Temasek&comma; Grosvenor’s Wheatsheaf Group&comma; and TO Ventures&period; Prosus Ventures also contributed to the funding&comma; marking its first investment in synthetic biology&period;<&sol;p>&NewLine;<p>The Series C round raised by EVERY was oversubscribed due to strong investor appetite to fill the growing supply gap for animal-free protein and ingredient solutions&period; &OpenCurlyDoubleQuote;The global demand for alternative proteins has grown substantially&comma; but the infrastructure needed to produce the necessary ingredients has yet to catch up&period; EVERY’s platform is a big step towards filling that gap&comma;” said Katrin Burt&comma; Managing Partner of Grosvenor’s Wheatsheaf Group&period;<&sol;p>&NewLine;<p>The Series C round brings EVERY’s total funding to &dollar;233 million&period; EVERY plans to use the capital to scale production&comma; commercialize a robust pipeline of animal-free protein products nationwide&comma; and expand into a broad array of new food applications&period; EVERY™ will also continue to expand its protein production platform by mining the egg proteome for novel&comma; hyper-functional proteins&period;<&sol;p>&NewLine;<p>&OpenCurlyDoubleQuote;It’s rare for a company to credibly claim revolutionizing a century-old industry&period; Arturo and the team at EVERY are doing just that&comma;” said Gabriel Ruimy&comma; Managing Partner of Rage Capital&period; &OpenCurlyDoubleQuote;By leveraging precision fermentation technologies&comma; EVERY™ is bringing ingredient synthesis from science fiction to supermarket aisles&comma; starting with egg proteins and enzymes&period; We look forward to supporting the company in the commercialization of such exciting innovation in the next years&period;”<&sol;p>&NewLine;<p>EVERY has pioneered a disruptive advance in food technology by developing a platform that produces real animal proteins without the use of a single animal&period; Last year&comma; it launched the world’s first animal-free pepsin with Fortune 500 ingredients company&comma; Ingredion&period; Most recently&comma; it launched the world’s first animal-free egg protein&period; In November&comma; EVERY made its retail debut by announcing a limited time partnership with leading national cold-pressed juice brand Pressed to serve the world’s first nature-equivalent animal-free protein smoothie directly to consumers for the first time&period;<&sol;p>&NewLine;<p>&OpenCurlyDoubleQuote;The restaurant industry is one of the early adopters of new food technologies and their introduction to the consumer&period; Given our deep roots in restaurants and as a prolific investor in the leading alternative protein companies&comma; McWin is uniquely equipped to support EVERY’s ambitious plans to bring its products to menus worldwide&comma;” said Henry McGovern&comma; founder of McWin Food Ecosystem Fund and AmRest&comma; which operates over 2&comma;300 restaurants globally&period; &OpenCurlyDoubleQuote;Eggs are not only ubiquitous&comma; but they are also incredibly difficult to replace&semi; we see tremendous potential in EVERY’s revolutionary technology&period;”<&sol;p>&NewLine;<p>&OpenCurlyDoubleQuote;There has never been a better time to be a B2B ingredients platform&comma;” said Arturo Elizondo&comma; CEO &amp&semi; founder of The EVERY Company&period; &OpenCurlyDoubleQuote;As the world’s biggest food companies work to evolve their product offerings into the 21st century by driving for cleaner&comma; kinder&comma; and more sustainable labels&comma; the options available are few and far between&period; We at EVERY™ are perfectly positioned to enable the world’s largest and smallest food companies to transition to an animal-free future –– without compromises&period; Now&comma; our major objective is to scale the platform to make good on our promise to bring our proteins to everyone&comma; everywhere&period; This new injection of capital will allow us to do just that&period;”<&sol;p>&NewLine;

Editor

IBM Acquiring Confluent for $11 Billion

ARMONK, NY -- IBM has agreed to buy Confluent, Inc., the data streaming pioneer, for…

2 days

Marvell Buying Celestial AI for $3.25 Billion+

SANTA CLARA -- Marvell Technology, Inc., a leader in data infrastructure semiconductor solutions, plans to…

2 days

ALM Ventures Debuts $100 Million Fund

MOUNTAIN VIEW -- ALM Ventures has announced the launch of ALM Ventures Fund I, a…

5 days

Brainworks Ventures Launches $50 Million AI-Native Fund

SAN FRANCISCO -- Brainworks Ventures, an AI-native venture capital fund led by DARPA alumnus Dr.…

5 days

OpenAI Hires New Chief Revenue Officer

OpenAI is hiring Slack CEO Denise Dresser as the company's Chief Revenue Officer, overseeing global…

5 days

Teen Charged With Shooting at Westfield Valley Fair Mall

The Santa Clara County District Attorney’s Office has charged a San Jose 17-year-old with attempted…

5 days